Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2014; 11(1):80-86. doi:10.7150/ijms.5585 This issue Cite

Research Paper

Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology

Sung-Jong Lee1, Ah-Won Lee2, Chang-Suk Kang2, Jong-Sup Park3, Dong-Choon Park1, Eun-Young Ki3, Keun-Ho Lee3, Joo-Hee Yoon1, Soo-Young Hur3, Tae-Jung Kim2✉

1. Department of Obstetrics and Gynecology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Republic of Korea
2. Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
3. Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

✉ Corresponding author: Tae-Jung Kim, Department of Hospital Pathology, Yeouido St. Mary's Hospital, 62 Yeouido-dong Yongdeungpo-gu, Seoul, Republic of Korea (Postal code: 150-010). Phone: +82-2-3779-2157; Fax: +82-2-783-6648; Email: kimecho More

Citation:
Lee SJ, Lee AW, Kang CS, Park JS, Park DC, Ki EY, Lee KH, Yoon JH, Hur SY, Kim TJ. Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology. Int J Med Sci 2014; 11(1):80-86. doi:10.7150/ijms.5585. https://www.medsci.org/v11p0080.htm
Other styles

File import instruction

Abstract

Background: The objective of this study was to investigate the expression of human papilloma virus (HPV) L1 capsid protein in abnormal cervical cytology with HPV16 infection and analyze its association with cervical histopathology in Korean women.

Material and Methods: We performed immunocytochemistry for HPV L1 in 475 abnormal cervical cytology samples from patients with HPV16 infections using the Cytoactiv® HPV L1 screening set. We investigated the expression of HPV L1 in cervical cytology samples and compared it with the results of histopathological examination of surgical specimens.

Results: Of a total of 475 cases, 188 (39.6%) were immunocytochemically positive and 287 (60.4%) negative for HPV L1. The immunocytochemical expression rates of HPV L1 in atypical squamous cells of unknown significance (ASCUS), low-grade squamous intraepithelial lesions (LSIL), high-grade squamous intraepithelial lesions (HSIL), and cancer were 21.8%, 59.7%, 19.1%, and 0.0%, respectively. LSIL exhibited the highest rate of HPV L1 positivity. Of a total of 475 cases, the multiple-type HPV infection rate, including HPV16, in HPV L1-negative cytology samples was 27.5%, which was significantly higher than that in HPV L1-positive cytology samples (p = 0.037). The absence of HPV L1 expression in ASCUS and LSIL was significantly associated with high-grade (≥cervical intraepithelial neoplasia [CIN] 2) than low-grade (≤CIN1) histopathology diagnoses (p < 0.05), but was not significantly different between HPV16 single and multiple-type HPV infections (p > 0.05). On the other hand, among 188 HPV L1-positive cases, 30.6% of multiple-type HPV infections showed high-grade histopathology diagnoses (≥CIN3), significantly higher than the percentage of HPV16 single infections (8.6%) (p = 0.0004)

Conclusions: Our study demonstrates that the expression of HPV L1 is low in advanced dysplasia. Furthermore, the absence of HPV L1 in HPV16-positive low-grade cytology (i.e., ASCUS and LSIL) is strongly associated with high-grade histopathology diagnoses. The multiplicity of HPV infections may have an important role in high-grade histopathology diagnoses (≥CIN3) in HPV L1-positive cases.

Keywords: cervical cancer, cervical intraepithelial neoplasia, human papillomavirus, immunocytochemistry, cervical cytology

Citation styles

APA
Lee, S.J., Lee, A.W., Kang, C.S., Park, J.S., Park, D.C., Ki, E.Y., Lee, K.H., Yoon, J.H., Hur, S.Y., Kim, T.J. (2014). Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology. International Journal of Medical Sciences, 11(1), 80-86. https://doi.org/10.7150/ijms.5585.

ACS
Lee, S.J.; Lee, A.W.; Kang, C.S.; Park, J.S.; Park, D.C.; Ki, E.Y.; Lee, K.H.; Yoon, J.H.; Hur, S.Y.; Kim, T.J. Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology. Int. J. Med. Sci. 2014, 11 (1), 80-86. DOI: 10.7150/ijms.5585.

NLM
Lee SJ, Lee AW, Kang CS, Park JS, Park DC, Ki EY, Lee KH, Yoon JH, Hur SY, Kim TJ. Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology. Int J Med Sci 2014; 11(1):80-86. doi:10.7150/ijms.5585. https://www.medsci.org/v11p0080.htm

CSE
Lee SJ, Lee AW, Kang CS, Park JS, Park DC, Ki EY, Lee KH, Yoon JH, Hur SY, Kim TJ. 2014. Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology. Int J Med Sci. 11(1):80-86.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use